Unicycive Therapeutics Provides Update from FDA Type A Meeting and Expects to Resubmit OLC NDA Before Year-End

Cash runway into 2027, which is expected to support application resubmission, potential FDA approval, and launch of OLCLOS ...

Acquisition of Option to Buy Lepidico's Interest in Karibib Lithium, Rubidium and Cesium Project in Namibia - Update

International Lithium Corp. (TSXV: ILC) (OTCQB: ILHMF) (FSE: IAH) (the "Company" or "ILC") is pleased to announce, further to its announcement on September 09, 2025, that on October 24, 2025 Lepidico ...